In recent market analysis, Gaurang Shah of Geojit Financial Services expressed his bullish outlook on Piramal Pharma, citing strong fundamentals and growth potential in the pharmaceutical sector. The company's strategic positioning, coupled with industry trends, makes it an attractive option for long-term investors.
MPW Special Issue Unveiled | Celebrating India’s Most Powerful Women | #BTMPW2025
India–U.S. Trade Exports Rise To $1.3 Bn, Resilient Despite Tariffs Deal Talks Ongoing
Helios Luxe Brings Swiss Watch Brand To India
Who Is Nitin Nabin? BJP’s New Working President, Five-Time MLA And Proven Bihar Leader
Rupee Hits Record Low: Why RBI Is Holding Back, Sudip Bandyopadhyay Explains
